Bröckelmann, P. J., Böll, B., Molin, D., Schneider, G., Leppä, S., Meißner, J., . . . Fosså, A. (2025). Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients. HemaSphere, 9(8), . https://doi.org/10.1002/hem3.70190
Chicago Style (17th ed.) CitationBröckelmann, Paul Jan, et al. "Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisone for Advanced-stage Hodgkin Lymphoma in Older Patients." HemaSphere 9, no. 8 (2025). https://doi.org/10.1002/hem3.70190.
MLA (9th ed.) CitationBröckelmann, Paul Jan, et al. "Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisone for Advanced-stage Hodgkin Lymphoma in Older Patients." HemaSphere, vol. 9, no. 8, 2025, https://doi.org/10.1002/hem3.70190.